Meeting Register Page

The “Phase 0” Global Center for Medical Innovation (CGMI) Product Development Process, a CNYBAC Concept to Commercialization Virtual Series Presentation
Michael Fisher, Director of Product Development at GCMI, will discuss their “Phase 0” product development process. This process helps develop a project plan, understand development costs and timelines, realize overall product opportunities, and estimate the product’s true value proposition. Through collection of data, the client has an opportunity to challenge findings, question their own assumptions, prepare a defensible strategy to discuss with investors, and compete for various grant applications. Most importantly, this process helps the client spend their limited resources to make the best decisions for their company.
The Phase 0 includes:
1. Regulatory Pathway (how others went through the approval process and what will be expected for your project)
2. Clinical Need (disease state, the patient care pathway, prevalence of pathology, alternative treatment paradigms, etc.)
3. Market Analysis (competitors, average sales prices, healthcare economics, etc.)
4. Intellectual Properties (patent landscape, key players, potential white space, and freedom to operate)
5. Technology (basic user needs and product specifications, benchmark testing of competitive devices, and prototyping)

Feb 9, 2022 03:00 PM in Eastern Time (US and Canada)

* Required information